Saturday, July 18, 2015 11:15:42 PM
Recent CDXC News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 09:47:21 PM
- ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide • Business Wire • 11/07/2024 01:32:00 PM
- ChromaDex Corporation Reports Third Quarter 2024 Financial Results • Business Wire • 10/31/2024 08:04:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:01:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2024 08:00:43 PM
- ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 • Business Wire • 10/28/2024 12:32:00 PM
- ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 • Business Wire • 10/24/2024 12:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2024 09:04:08 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2024 09:03:24 PM
- ChromaDex to Participate in the 17th Annual LD Micro Main Event • Business Wire • 10/23/2024 12:34:00 PM
- Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) • Business Wire • 10/15/2024 12:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:00:30 PM
- ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference • Business Wire • 09/26/2024 08:12:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:32:40 PM
- ChromaDex Appoints Ozan Pamir as Chief Financial Officer • Business Wire • 09/20/2024 12:32:00 PM
- ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics • Business Wire • 09/10/2024 12:32:00 PM
- ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions • Business Wire • 09/09/2024 12:34:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 11:06:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 03:52:27 PM
- ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 • Business Wire • 08/23/2024 12:34:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 10:15:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 10:15:03 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 10:06:58 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 10:05:57 AM
- ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ • Business Wire • 08/19/2024 12:32:00 PM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM